Standards > reporting guideline > bsg-s000159


ready Minimum Information About a Bioactive Entity

Abbreviation:MIABE


General Information
Reporting requirements for the publication of data on one or a series of bioactive entities, such as pharmaceuticals and pesticides. The work on MIABE was initiated as part of the EMBL-EBI Industry Programme and carried out by EMBL-EBI and the PSI-MI work group.

Collected/Recommended By



Record updated: Nov. 29, 2016, 9:37 p.m. by Madekale.



Support

Additional Information


Tools

    No tools defined


Conditions of Use

License

No License Specified.


Schemas

No XSD schemas defined


Access / Retrieve Data

Conditions of Use

No License Specified.





Connectivity
Related Standards

Terminology Artifacts

No semantic standards defined

Models and Formats

No syntax standards defined


Implementing Databases (1)
canSAR
canSAR is an integrated cancer research and drug discovery resource that brings together large-scale data from different disciplines and allows query and exploration to help cancer research and drug discovery.

Implementing Policies

This record is not implemented by any policy.


Credit

Record Maintainer

  • This record is in need of a maintainer. If you login, you'll be able to claim this record.

Funding agency

Maintainer

Grant Number(s)

  • 086151 (Wellcome Trust, UK)

  • BB/1000/488/1 (Biotechnology and Biological Sciences Research Council (BBSRC), UK)

  • BBS/E/C/00004973 (Biotechnology and Biological Sciences Research Council (BBSRC), UK)


Publications

Minimum information about a bioactive entity (MIABE).

Orchard S,Al-Lazikani B,Bryant S,Clark D,Calder E,Dix I,Engkvist O,Forster M,Gaulton A,Gilson M,Glen R,Grigorov M,Hammond-Kosack K,Harland L,Hopkins A,Larminie C,Lynch N,Mann RK,Murray-Rust P,Lo Piparo E,Southan C,Steinbeck C,Wishart D,Hermjakob H,Overington J,Thornton J
Nat Rev Drug Discov 2011

View Paper (PubMed) View Paper (DOI)